Endoluminal therapy for Barrett's esophagus

Area of Science:

• Gastroenterology and Endoscopic Therapeutics
• Oncology and Cancer Prevention

Background:

• Barrett's esophagus carries a risk of progression to high-grade dysplasia and invasive adenocarcinoma.
• Traditional management for high-grade dysplasia and early cancer involves operative esophageal resection, carrying significant surgical risks.
• Endoscopic therapies offer a less invasive alternative for managing Barrett's esophagus.

Purpose of the Study:

• To review methods for minimizing complications associated with endoscopic therapy for Barrett's esophagus.
• To contextualize endoscopic therapies within the natural history of Barrett's esophagus and surgical risks.
• To categorize and review currently approved endoscopic ablation and resection techniques.

Main Methods:

• Review of the natural history of Barrett's esophagus and risks of malignant progression.
• Analysis of risks associated with traditional operative esophageal resection.
• Categorization and review of commercially available endoscopic ablation (focal, field) and resection methods.
• Evaluation of clinical experience, adverse events, and complications for each endoscopic modality.

Main Results:

• Various endoscopic ablation and resection techniques are available for Barrett's esophagus.
• Each endoscopic method has associated adverse events and complications that require careful management.
• Clinical experience highlights the promise of these technologies in preventing invasive carcinoma.

Conclusions:

• Endoscopic therapies are crucial for managing Barrett's esophagus and preventing cancer.
• Understanding and minimizing procedural complications is essential for successful patient outcomes.
• Recommendations are provided to guide the safe and effective use of these advanced endoscopic technologies.